Auxilius · 21 hours ago
Clinical Analyst
Auxilius is a fast-growing, venture-backed B2B SaaS company transforming how innovative biotechs operate. They are seeking a Clinical Analyst to join their Operations team, where the candidate will ensure accurate clinical and operational data, guide product improvements, and support client onboarding and training.
Responsibilities
Support accounting workflows by configuring clinical data in the Auxilius platform (e.g., CTA-driven costs leveraging EDC)
Support client onboarding, enablement, and training focused on clinical cost tracking and budgeting
Perform QA/QC audits of clinical trial financial data to ensure accuracy and alignment with trial activity
Analyze discrepancies and identify root causes across clinical and financial data
Investigate and resolve client issues related to clinical accounting data
Clearly communicate findings, corrections, and outcomes to clients
Support product testing for clinical accounting features
Translate client feedback and workflow gaps into actionable product roadmap input
Ensure compliance with client-specific controls, policies, and clinical accounting requirements
Qualification
Required
Bachelor's degree in Life Sciences, Healthcare, Business, or related field
2+ years in clinical operations, biotech, or related fields
Strong analytical skills
proficiency with Excel
Detail-oriented with a process-focused mindset
Ability to work independently and manage multiple priorities
Collaborative, positive attitude with a sense of humor
Preferred
startup experience preferred
familiarity with clinical or operational software a plus
Benefits
Premium healthcare
Access to modern health partners like One Medical, Kindbody, Talkspace, and Teladoc
Flexible Spending Account
401(k) that matches 100% of the first 1% you contribute and 50% of the next 5%
Life and disability insurance
Commuter benefits
24/7 well-being resources through Health Advocate
Unlimited PTO
Company
Auxilius
Auxilius provides clinical trial financial management software for Biopharma.
Funding
Current Stage
Early StageTotal Funding
$20MKey Investors
SignalFireRenegade Partners
2024-03-15Series A· $10M
2022-06-16Series A· $10M
Recent News
Company data provided by crunchbase